Suhagra 25 mg, like other dosages of Suhagra, contains the active ingredient sildenafil citrate. Sildenafil citrate is classified as a phosphodiesterase type 5 (PDE5) inhibitor.
Phosphodiesterase type 5 (PDE5) is an enzyme found mainly in the smooth muscle cells lining the blood vessels of the penis. It plays a role in regulating blood flow to the erectile tissue of the penis.
When a man becomes sexually aroused, nitric oxide (NO) is released in Suhagra 25 mg erectile tissue. Nitric oxide then activates an enzyme called guanylate cyclase, which leads to increased levels of cyclic guanosine monophosphate (cGMP). cGMP relaxes the smooth muscle cells of the penile blood vessels, allowing them to dilate and increase blood flow into the penis, resulting in an erection.
PDE5, however, breaks down cGMP, leading to a decrease in its levels and a reduction in blood flow to the penis, which can result in difficulty achieving or maintaining an erection.
Sildenafil citrate works by inhibiting the action of PDE5, thus preventing the breakdown of cGMP. By doing so, it helps to maintain higher levels of cGMP in the penis, promoting relaxation of the smooth muscle cells and increasing blood flow, which facilitates the achievement and maintenance of an erection.
Therefore, Suhagra 25 mg, containing sildenafil citrate, is considered a phosphodiesterase type 5 (PDE5) inhibitor because it acts on the PDE5 enzyme to enhance the natural physiological process of penile erection.
Phosphodiesterase type 5 (PDE5) is an enzyme found mainly in the smooth muscle cells lining the blood vessels of the penis. It plays a role in regulating blood flow to the erectile tissue of the penis.
When a man becomes sexually aroused, nitric oxide (NO) is released in Suhagra 25 mg erectile tissue. Nitric oxide then activates an enzyme called guanylate cyclase, which leads to increased levels of cyclic guanosine monophosphate (cGMP). cGMP relaxes the smooth muscle cells of the penile blood vessels, allowing them to dilate and increase blood flow into the penis, resulting in an erection.
PDE5, however, breaks down cGMP, leading to a decrease in its levels and a reduction in blood flow to the penis, which can result in difficulty achieving or maintaining an erection.
Sildenafil citrate works by inhibiting the action of PDE5, thus preventing the breakdown of cGMP. By doing so, it helps to maintain higher levels of cGMP in the penis, promoting relaxation of the smooth muscle cells and increasing blood flow, which facilitates the achievement and maintenance of an erection.
Therefore, Suhagra 25 mg, containing sildenafil citrate, is considered a phosphodiesterase type 5 (PDE5) inhibitor because it acts on the PDE5 enzyme to enhance the natural physiological process of penile erection.